188 related articles for article (PubMed ID: 23330662)
41. Treatment of pyoderma gangrenosum with the anti-TNFalpha drug - Etanercept.
Rogge FJ; Pacifico M; Kang N
J Plast Reconstr Aesthet Surg; 2008; 61(4):431-3. PubMed ID: 18358433
[TBL] [Abstract][Full Text] [Related]
42. [A non-infectious pyodermatitis: Pyoderma gangrenosum].
Lambert J; Jonlet F; Vanhooteghem O; Richert B; de la Brassinne M
Rev Med Liege; 2001 Feb; 56(2):106-11. PubMed ID: 11294044
[TBL] [Abstract][Full Text] [Related]
43. Scrotal pyoderma gangrenosum associated with dermatomyositis.
Shah M; Lewis FM; Harrington CI
Clin Exp Dermatol; 1996 Mar; 21(2):151-3. PubMed ID: 8759207
[TBL] [Abstract][Full Text] [Related]
44. Pyoderma gangrenosum associated with biphenotypic acute leukemia.
Asai M; Aragane Y; Kawada A; Shimada T; Kanamaru A; Yamada H; Tezukam T
J Am Acad Dermatol; 2001 Mar; 44(3):530-1. PubMed ID: 11209130
[TBL] [Abstract][Full Text] [Related]
45. A case of pyoderma gangrenosum induced by insulin.
Noronha M; Arora S; Pai K; Sathish Pai B; Jindal A
Int Wound J; 2019 Oct; 16(5):1239-1242. PubMed ID: 31353778
[TBL] [Abstract][Full Text] [Related]
46. Pyoderma gangrenosum associated with hidradenitis suppurativa.
Ah-Weng A; Langtry JA; Velangi S; Evans CD; Douglas WS
Clin Exp Dermatol; 2005 Nov; 30(6):669-71. PubMed ID: 16197385
[TBL] [Abstract][Full Text] [Related]
47. Combination immunosuppressant therapy for rapidly progressive pyoderma gangrenosum in a child.
Kawabe S; Iwata N; Nishida E; Kohagura T; Abe N; Nakaseko H; Morita A
Mod Rheumatol Case Rep; 2021 Jan; 5(1):137-140. PubMed ID: 33016252
[TBL] [Abstract][Full Text] [Related]
48. Pyoderma gangrenosum: clinical presentation and outcome in 18 cases and review of the literature.
Hasselmann DO; Bens G; Tilgen W; Reichrath J
J Dtsch Dermatol Ges; 2007 Jul; 5(7):560-4. PubMed ID: 17610605
[TBL] [Abstract][Full Text] [Related]
49. Pyoderma gangrenosum associated with the secondary antiphospholipid syndrome.
Schmid MH; Hary C; Marstaller B; Konz B; Wendtner CM
Eur J Dermatol; 1998; 8(1):45-7. PubMed ID: 9649713
[TBL] [Abstract][Full Text] [Related]
50. [An uncommon localization of pyoderma gangrenosum on the penis of an HIV infected patient in the Ivory Coast].
Ecra E; Ahogo KC; Sangaré A; Kaloga M; Kassi K; Kouamé K; Kacou DE; Gbery IP; Yoboué YP; Kanga JM
Bull Soc Pathol Exot; 2009 May; 102(2):85-7. PubMed ID: 19583026
[TBL] [Abstract][Full Text] [Related]
51. Disseminated superficial porokeratosis and pyoderma gangrenosum.
di Meo N; Fluehler C; Perkan V; Trevisan G
Dermatol Online J; 2010 Oct; 16(10):15. PubMed ID: 21062609
[TBL] [Abstract][Full Text] [Related]
52. Successful treatment of pyoderma gangrenosum with topical 0.5% nicotine cream.
Patel GK; Rhodes JR; Evans B; Holt PJ
J Dermatolog Treat; 2004 Apr; 15(2):122-5. PubMed ID: 15204166
[TBL] [Abstract][Full Text] [Related]
53. Optimal treatment of pyoderma gangrenosum.
Gettler S; Rothe M; Grin C; Grant-Kels J
Am J Clin Dermatol; 2003; 4(9):597-608. PubMed ID: 12926978
[TBL] [Abstract][Full Text] [Related]
54. Diagnosis and novel clinical treatment strategies for pyoderma gangrenosum.
Goldust M; Hagstrom EL; Rathod D; Ortega-Loayza AG
Expert Rev Clin Pharmacol; 2020 Feb; 13(2):157-161. PubMed ID: 31875484
[No Abstract] [Full Text] [Related]
55. Letter: Treatment-resistant pyoderma gangrenosum.
Kosari P; Feldman SR
Dermatol Online J; 2012 Apr; 18(4):8. PubMed ID: 22559023
[TBL] [Abstract][Full Text] [Related]
56. Effective strategies for the management of pyoderma gangrenosum: a comprehensive review.
Patel F; Fitzmaurice S; Duong C; He Y; Fergus J; Raychaudhuri SP; Garcia MS; Maverakis E
Acta Derm Venereol; 2015 May; 95(5):525-31. PubMed ID: 25387526
[TBL] [Abstract][Full Text] [Related]
57. Pyoderma gangrenosum induced by episiotomy.
Alani A; Sadlier M; Ramsay B; Ahmad K
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26786531
[TBL] [Abstract][Full Text] [Related]
58. Efficacy of Systemic Dapsone Treatment for Pyoderma Gangrenosum: A Retrospective Review.
Din RS; Tsiaras WG; Li DG; Mostaghimi A
J Drugs Dermatol; 2018 Oct; 17(10):1058-1060. PubMed ID: 30365585
[TBL] [Abstract][Full Text] [Related]
59. Feasibility of conservative medical treatment for pyoderma gangrenosum.
Fioramonti P; Onesti MG; Fino P; Di Ronza S; Sorvillo V; Persichetti P
In Vivo; 2012; 26(1):157-9. PubMed ID: 22210732
[TBL] [Abstract][Full Text] [Related]
60. Gulliver's sign: A recognizable transition from inflammatory to healing stages of pyoderma gangrenosum.
Landis ET; Taheri A; Jorizzo JL
J Dermatolog Treat; 2015 Apr; 26(2):171-2. PubMed ID: 24552122
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
